TradeFlare's AI research teams analysed RCUS on 9 market nights between April 22, 2026 and July 29, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| July 29, 2026 | BUY | $27.05 | — / — | +4.7% | +16.3% | The current market regime and stock-specific fundamentals do not support a buy recommendation. |
| July 17, 2026 | BUY | $26.64 | — / — | +3.8% | +7.7% | Ongoing clinical collaborations may yield positive data. |
| July 16, 2026 | BUY | $28.02 | — / — | +11.6% | +8.3% | The stock is currently in a neutral market regime with mixed signals and a bearish fundamental outlook, making it unsuitable for a buy recommendation. |
| June 30, 2026 | BUY | $31.08 | $37.30 / $26.42 | -1.9% | -14.2% | The post-earnings drift signal suggests momentum could persist for several weeks. |
| June 26, 2026 | BUY | $30.25 | $37.81 / $25.71 | -3.3% | -10.2% | The post-earnings drift pattern suggests a sustained upward move over the coming weeks. |
| June 25, 2026 | BUY | $28.80 | $33.12 / $24.48 | +0.3% | -6.0% | The post-earnings drift signal suggests continued upward momentum over the coming weeks. |
| May 19, 2026 | BUY | $23.78 | — / — | +5.4% | +6.0% | The current market conditions and the stock's technicals do not present a clear, high-conviction opportunity for entry. |
| May 18, 2026 | BUY | $23.78 | — / — | +3.1% | +0.6% | The current market conditions and the stock's technicals do not present a clear, high-conviction opportunity for entry. |
| April 22, 2026 | BUY | $24.52 | — / — | -9.3% | -10.8% | The market is neutral, and while fundamentals are bullish, technicals are neutral and risk is high, requiring a clearer technical setup. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.